SAPU NANO (EU) LIMITED

Overview

SAPU NANO (EU) LIMITED is a precision nanomedicine company based in Ireland, operating under CRO number 780938. The company develops next-generation oncology therapeutics focused on rare pediatric and adult cancers, utilizing its Deciparticle™ platform to deliver sub-20nm nanoparticles for enhanced tumor penetration and improved biodistribution. Its clinical pipeline includes SAPU-003, a Phase 1/2 everolimus-based therapy in development, alongside other preclinical and early-stage programs. The technology aims to overcome delivery barriers in solid tumors through programmable, ultrasmall drug delivery systems. The company has global development ambitions, with operations and research extending to the US, Europe, Australia, and Asia. It emphasizes 30+ years of nanomedicine expertise and focuses on precision delivery for oncology applications. Beyond registry-level identification, no further business details are publicly captured.

Location & registered address

Nathan Trust Registered Office Services

First Floor

Penrose 2

Penrose Dock

Cork

Ireland

Industry classification

NACE Rev. 2 — 21.10

→ All NACE 21.10 companies in Ireland · In Cork